DS STAGE III MULTIPLE MYELOMA
Clinical trials for DS STAGE III MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new DS STAGE III MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for DS STAGE III MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for untreated myeloma patients
Disease control OngoingThis phase 3 trial tests whether adding bortezomib to lenalidomide and dexamethasone works better than lenalidomide and dexamethasone alone for people with newly diagnosed multiple myeloma who are not planning an immediate stem cell transplant. The study involves 525 participants…
Matched conditions: DS STAGE III MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 03:13 UTC
-
New combo therapy shows promise in battling blood cancer
Disease control OngoingThis study tested two different doses of dexamethasone combined with lenalidomide in 452 people newly diagnosed with multiple myeloma, a type of blood cancer. The goal was to see which dose worked better at shrinking tumors. If the first treatment didn't work, patients could rece…
Matched conditions: DS STAGE III MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Can a pill keep myeloma at bay after transplant? major trial seeks answers
Disease control OngoingThis study tested whether taking lenalidomide (a drug that helps the immune system fight cancer) after a stem cell transplant could delay the return of multiple myeloma. About 460 patients who had already received a transplant were randomly given either lenalidomide or a placebo.…
Matched conditions: DS STAGE III MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC